Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CRKL |
| Upstream (Parents) |
|---|
| (<<) ACTB → CRKL |
| (<<) BCL2L13 → CRKL |
| (<<) DHX9 → CRKL |
| (<<) ERBB2 → CRKL |
| (<<) MAP3K2 → CRKL |
| (<<) MAT2A → CRKL |
| (<<) MCL1 → CRKL |
| (<<) PRPF4B → CRKL |
| (<<) PTPN11 → CRKL |
| (<<) RAB5A → CRKL |
| (<<) RXRB → CRKL |
| (<<) SPPL2B → CRKL |
| (<<) YWHAE → CRKL |
| (<<) YWHAZ → CRKL |
| Downstream (Children) |
|---|
| CRKL → ADAM17 (>>) |
| CRKL → ATF2 (>>) |
| CRKL → CASP2 (>>) |
| CRKL → CYP1B1 (>>) |
| CRKL → EPHA2 (>>) |
| CRKL → GNA13 (>>) |
| CRKL → HSPA9 (>>) |
| CRKL → MAP3K1 (>>) |
| CRKL → MEGF6 (>>) |
| CRKL → MEX3D (>>) |
| CRKL → MKNK1 (>>) |
| CRKL → PDE4C (>>) |
| CRKL → PIK3C3 (>>) |
| CRKL → RAD51L3 (>>) |
| CRKL → RPS14 (>>) |
| CRKL → TP53 (>>) |
| CRKL → YRDC (>>) |
